2001
DOI: 10.1128/iai.69.8.5010-5015.2001
|View full text |Cite
|
Sign up to set email alerts
|

Meningococcal Outer Membrane Vesicle Vaccine Given Intranasally Can Induce Immunological Memory and Booster Responses without Evidence of Tolerance

Abstract: We have studied the ability of outer membrane vesicle (OMV) vaccines from Neisseria meningitidis serogroup B to induce vaccine-specific antibody and spleen cell proliferative responses in mice after being administered intranasally (i.n.) and/or subcutaneously (s.c.). A series of four weekly i.n. doses (25 g) without adjuvant or a single s.c. dose (2.5 g) with aluminum hydroxide was followed 2 months later by secondary i.n. or s.c. immunizations. After i.n. priming, both immunoglobulin G (IgG) antibody response… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
16
0
2

Year Published

2003
2003
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 22 publications
1
16
0
2
Order By: Relevance
“…with four weekly doses of the Norwegian DOMV vaccine, SBA titers did not increase after a new round of i.n. immunizations (9). We have previously made similar observations when mice were immunized with NOMVs (unpublished results).…”
Section: Vol 72 2004 Local and Systemic Responses To N Meningitidisupporting
confidence: 66%
See 1 more Smart Citation
“…with four weekly doses of the Norwegian DOMV vaccine, SBA titers did not increase after a new round of i.n. immunizations (9). We have previously made similar observations when mice were immunized with NOMVs (unpublished results).…”
Section: Vol 72 2004 Local and Systemic Responses To N Meningitidisupporting
confidence: 66%
“…Interestingly, a significant increase in SBA titer was found in mice primed i.n. and boosted subcutaneously with one dose of DOMV vaccine (9). Whether humans would benefit from this immunization schedule for OMV vaccines remains to be determined.…”
Section: Vol 72 2004 Local and Systemic Responses To N Meningitidimentioning
confidence: 99%
“…Intestinal or nasal antigen uptake may result in peripheral tolerance, and this was the starting point of the present work with disease-promoting parasite antigens. However, systemic immunity may also be achieved after antigen administration through the mucosa (1), and the balance between tolerance and immunity is a function of the nature of the antigen, the antigen dosage, the antigen form (soluble or particulated), the site of antigen administration, and the associa- (23). Thus, it seems that although both the nasal and oral mucosa may be sites for effective vaccination with LaAg, the antigen may be differentially presented at the two sites, as indicated by the partial tolerance and the active systemic immunity, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…OMV not only disseminate toxins and enzymes into host cells to protect bacterial survival but also serve as bacterium-like decoys to neutralize the host immune responses and facilitate Gram-negative pathogens' immune evasion (10,71). OMV delivery of antigens has been a large area of investigation, as OMV could improve vaccines by delivery to the major histocompatibility complex (MHC) class I pathway while simultaneously providing pathogen-associated molecular patterns as adjuvants (2,4,62,73). Based on the accumulative observations of OMV in a variety of microorganisms, multiple biological functions of OMV, including virulence attributes and its biogenesis, including production mechanism and cargo selectivity have been reviewed recently (1,21,46).…”
mentioning
confidence: 99%